BIO
Bio-Rad Laboratories Inc
NYSE: BIO · HEALTHCARE · MEDICAL DEVICES
$275.15
-1.50% today
Updated 2026-04-29
Market cap
$7.43B
P/E ratio
9.88
P/S ratio
2.88x
EPS (TTM)
$27.85
Dividend yield
—
52W range
$211 – $343
Volume
0.3M
Bio-Rad Laboratories Inc (BIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $118.23M | $191.58M | $191.37M | $325.07M | $225.91M | $262.74M | $266.48M | $169.14M | $273.31M | $186.21M | $216.07M | $104.14M | $285.49M | $457.90M | $584.97M | $656.52M | $194.45M | $374.94M | $455.20M | $532.20M |
| Capital expenditures | $52.99M | $62.67M | $88.81M | $76.36M | $92.53M | $103.32M | $144.65M | $107.36M | $136.48M | $113.37M | $141.57M | $115.13M | $129.83M | $98.53M | $108.56M | $120.80M | $114.16M | $156.68M | $189.00M | $157.60M |
| Depreciation | $55.40M | $67.30M | $97.10M | $101.70M | $108.90M | $121.00M | $130.40M | $147.20M | $149.90M | $131.80M | $142.90M | $148.70M | $138.10M | $134.24M | $138.60M | $133.80M | $137.30M | $145.90M | $151.60M | $205.40M |
| Stock-based comp | $5.40M | — | $7.30M | $9.10M | $10.20M | $10.70M | $13.20M | $13.70M | $14.90M | $17.00M | $19.70M | $23.40M | $27.80M | $35.60M | $41.60M | $51.20M | $60.90M | $61.30M | $62.30M | $58.00M |
| Free cash flow | $65.24M | $128.91M | $102.56M | $248.71M | $133.38M | $159.41M | $121.83M | $61.78M | $136.83M | $72.84M | $74.50M | $-10.99M | $155.67M | $359.37M | $476.41M | $535.72M | $80.29M | $218.26M | $266.20M | $374.60M |
| Investing cash flow | $-207.75M | $-254.43M | $-146.11M | $-175.95M | $-216.51M | $-386.33M | $-400.39M | $919000.00 | $-190.51M | $-166.87M | $-213.88M | $-175.57M | $-186.98M | $-208.89M | $-69.89M | $-784.44M | $-1.21B | $20.21M | $-160.20M | $-189.70M |
| Financing cash flow | $10.16M | $-7.45M | $6.33M | $293.93M | $228.75M | $-213.56M | $12.59M | $-311.70M | $11.69M | $8.58M | $9.02M | $341000.00 | $-48.68M | $-22.76M | $-523.04M | $-55.43M | $973.58M | $-425.65M | $-218.80M | $-283.20M |
| Dividends paid | — | — | — | — | $0.00 | $0.00 | $10.51M | $0.00 | $0.00 | $0.00 | — | $4.37M | — | $3.83B | $20.20M | $35.28B | $68.18B | $100.10B | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $256.61M | — | $-110.84M | $-131.84M | $81.70M | $44.30M | $-1.28M | $-72.44M | $49.18M | $228.49M | $4.46M | $-195.98M | $-39.57M | — | — | — |